NCS Healthcare of Kentucky Inc

FDA Regulatory Profile

NCS Healthcare of Kentucky Inc appears in FDA public data with 3 recalls, 0 510(k) clearances, 6 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0113-2024, Class III) was initiated on October 27, 2023.

Summary

Total Recalls
3
510(k) Clearances
0
Inspections
6
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0113-2024Class IIIBuspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 3October 27, 2023
D-0114-2024Class IIILisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count bOctober 27, 2023
D-0850-2020Class IIGlycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx OnlyJanuary 28, 2020